Literature DB >> 27689729

Natural and synthetic bioactive inhibitors of glycogen synthase kinase.

Imran Khan1, Mushtaq A Tantray1, Mohammad Sarwar Alam1, Hinna Hamid2.   

Abstract

Glycogen synthase kinase-3 is a multi-functional serine-threonine kinase and is involved in diverse physiological processes, including metabolism, cell cycle, and gene expression by regulating a wide variety of known substrates like glycogen synthase, tau-protein and β-catenin. Aberrant GSK-3 has been involved in diabetes, inflammation, cancer, Alzheimer's and bipolar disorder. In this review, we present an overview of the involvement of GSK-3 in various signalling pathways, resulting in a number of adverse pathologies due to its dysregulation. In addition, a detailed description of the small molecule inhibitors of GSK-3 with different mode of action discovered or specifically developed for GSK-3 has been presented. Furthermore, some clues for the future optimization of these promising molecules to develop specific drugs inhibiting GSK-3, for the treatment of associated disease conditions have also been discussed. Copyright Â
© 2016 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  ATP; Alzheimer's disease; Diabetes; Glycogen synthase kinase; Kinases; Phosphorylation

Mesh:

Substances:

Year:  2016        PMID: 27689729     DOI: 10.1016/j.ejmech.2016.09.058

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  14 in total

1.  Optimization of Indazole-Based GSK-3 Inhibitors with Mitigated hERG Issue and In Vivo Activity in a Mood Disorder Model.

Authors:  Federica Prati; Rosa Buonfiglio; Guido Furlotti; Claudia Cavarischia; Giorgina Mangano; Rossella Picollo; Laura Oggianu; Anna di Matteo; Silvana Olivieri; Graziella Bovi; Pier Francesca Porceddu; Angelo Reggiani; Beatrice Garrone; Francesco Paolo Di Giorgio; Rosella Ombrato
Journal:  ACS Med Chem Lett       Date:  2020-03-24       Impact factor: 4.345

2.  The pivotal role of glycogen synthase kinase 3 (GSK-3) in vomiting evoked by specific emetogens in the least shrew (Cryptotis parva).

Authors:  W Zhong; N A Darmani
Journal:  Neurochem Int       Date:  2019-11-15       Impact factor: 3.921

3.  Semen Cassiae Extract Improves Glucose Metabolism by Promoting GlUT4 Translocation in the Skeletal Muscle of Diabetic Rats.

Authors:  Meiling Zhang; Xin Li; Hangfei Liang; Huqiang Cai; Xueling Hu; Yu Bian; Lei Dong; Lili Ding; Libo Wang; Bo Yu; Yan Zhang; Yao Zhang
Journal:  Front Pharmacol       Date:  2018-04-04       Impact factor: 5.810

Review 4.  Glycogen Synthase Kinase 3β in Cancer Biology and Treatment.

Authors:  Takahiro Domoto; Masahiro Uehara; Dilireba Bolidong; Toshinari Minamoto
Journal:  Cells       Date:  2020-06-03       Impact factor: 6.600

5.  Dysregulated levels of glycogen synthase kinase-3β (GSK-3β) and miR-135 in peripheral blood samples of cases with nephrotic syndrome.

Authors:  Mohammadreza Ardalan; Seyyedeh Mina Hejazian; Hassan Fazlazar Sharabiyani; Farahnoosh Farnood; Amirhossein Ghafari Aghdam; Milad Bastami; Elham Ahmadian; Sepideh Zununi Vahed; Magali Cucchiarini
Journal:  PeerJ       Date:  2020-12-16       Impact factor: 2.984

Review 6.  Mechanisms of Nausea and Vomiting: Current Knowledge and Recent Advances in Intracellular Emetic Signaling Systems.

Authors:  Weixia Zhong; Omar Shahbaz; Garrett Teskey; Abrianna Beever; Nala Kachour; Vishwanath Venketaraman; Nissar A Darmani
Journal:  Int J Mol Sci       Date:  2021-05-28       Impact factor: 5.923

7.  Analysis of the role of GSK3 in the mitotic checkpoint.

Authors:  M S Rashid; T Mazur; W Ji; S T Liu; W R Taylor
Journal:  Sci Rep       Date:  2018-09-24       Impact factor: 4.379

Review 8.  GSK3β: A Master Player in Depressive Disorder Pathogenesis and Treatment Responsiveness.

Authors:  Przemysław Duda; Daria Hajka; Olga Wójcicka; Dariusz Rakus; Agnieszka Gizak
Journal:  Cells       Date:  2020-03-16       Impact factor: 6.600

Review 9.  The Role of Brain Derived Neurotrophic Factor in HIV-Associated Neurocognitive Disorder: From the Bench-Top to the Bedside.

Authors:  Henry Michael; Thabisile Mpofana; Suvira Ramlall; Frasia Oosthuizen
Journal:  Neuropsychiatr Dis Treat       Date:  2020-01-31       Impact factor: 2.570

Review 10.  Aspartate β-hydroxylase as a target for cancer therapy.

Authors:  Madiha Kanwal; Michal Smahel; Mark Olsen; Jana Smahelova; Ruth Tachezy
Journal:  J Exp Clin Cancer Res       Date:  2020-08-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.